Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence (Q40671674)

22 September 2017

title

Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence (English)

1 reference

22 September 2017

main subject

anti-retroviral agent

0 references

1 reference

J H Wagner

1 reference

22 September 2017

A C Justice

1 reference

22 September 2017

M Chesney

1 reference

22 September 2017

G Sinclair

1 reference

22 September 2017

S Weissman

1 reference

22 September 2017

M Rodriguez-Barradas

1 reference

22 September 2017

VACS 3 Project Team

1 reference

22 September 2017

language of work or name

1 reference

1 December 2001

1 reference

Journal of Clinical Epidemiology

22 September 2017

published in

1 reference

22 September 2017

volume

54 Suppl 1

1 reference

22 September 2017

page(s)

S91-8

1 reference

Antiretroviral therapy: Factors associated with adherence

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Compliance in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Adherence in AIDS clinical trials: a framework for clinical research and clinical care

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Understanding and Improving Patient Compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Factors affecting adherence to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Time to stop counting the tablets?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

The natural history of medication compliance in a drug trial: limitations of pill counts

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

The electronic medication event monitor. Lessons for pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

A comparison study of multiple measures of adherence to HIV protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Compliance/adherence and care management in HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Problem drinking and medication adherence among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Determinants of virological response to antiretroviral therapy: implications for long-term strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Longitudinal HIV-1 RNA levels in a cohort of homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Veterans aging cohort three-site study (VACS 3): overview and description

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Screening with the Alcohol use Disorders Identification Test (AUDIT) in an inner-city population

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Clinical biostatistics. LIV. The biostatistics of concordance

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Factors associated with incomplete virological response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900450-4

7 January 2021

10.1016/S0895-4356(01)00450-4

Identifiers

DOI

1 reference

22 September 2017

1 reference